Artigo Revisado por pares

Three cases of classic Kaposi's sarcoma with different subtypes of Kaposi's sarcoma‐associated herpesvirus

2006; Wiley; Volume: 45; Issue: 7 Linguagem: Inglês

10.1111/j.1365-4632.2004.02465.x

ISSN

1365-4632

Autores

Agnieszka Beata Serwin, Hanna Myśliwiec, Natalie Wilder, Robert A. Schwartz, Bożena Chodynicka,

Tópico(s)

Parvovirus B19 Infection Studies

Resumo

International Journal of DermatologyVolume 45, Issue 7 p. 843-846 Three cases of classic Kaposi's sarcoma with different subtypes of Kaposi's sarcoma-associated herpesvirus Agnieszka B. Serwin MD, Agnieszka B. Serwin MD From the Department of Dermatology and Venereology, Medical University of Bialystok, Poland, Wolfson Institute for Biomedical Research, University College, London, United Kingdom, and Department of Dermatology, New Jersey Medical School, Newark, NJSearch for more papers by this authorHanna Mysliwiec MD, Hanna Mysliwiec MD From the Department of Dermatology and Venereology, Medical University of Bialystok, Poland, Wolfson Institute for Biomedical Research, University College, London, United Kingdom, and Department of Dermatology, New Jersey Medical School, Newark, NJSearch for more papers by this authorNatalie Wilder MD, Natalie Wilder MD From the Department of Dermatology and Venereology, Medical University of Bialystok, Poland, Wolfson Institute for Biomedical Research, University College, London, United Kingdom, and Department of Dermatology, New Jersey Medical School, Newark, NJSearch for more papers by this authorRobert A. Schwartz MD, MPD, Robert A. Schwartz MD, MPD From the Department of Dermatology and Venereology, Medical University of Bialystok, Poland, Wolfson Institute for Biomedical Research, University College, London, United Kingdom, and Department of Dermatology, New Jersey Medical School, Newark, NJSearch for more papers by this authorBozena Chodynicka MD, PhD, Bozena Chodynicka MD, PhD From the Department of Dermatology and Venereology, Medical University of Bialystok, Poland, Wolfson Institute for Biomedical Research, University College, London, United Kingdom, and Department of Dermatology, New Jersey Medical School, Newark, NJSearch for more papers by this author Agnieszka B. Serwin MD, Agnieszka B. Serwin MD From the Department of Dermatology and Venereology, Medical University of Bialystok, Poland, Wolfson Institute for Biomedical Research, University College, London, United Kingdom, and Department of Dermatology, New Jersey Medical School, Newark, NJSearch for more papers by this authorHanna Mysliwiec MD, Hanna Mysliwiec MD From the Department of Dermatology and Venereology, Medical University of Bialystok, Poland, Wolfson Institute for Biomedical Research, University College, London, United Kingdom, and Department of Dermatology, New Jersey Medical School, Newark, NJSearch for more papers by this authorNatalie Wilder MD, Natalie Wilder MD From the Department of Dermatology and Venereology, Medical University of Bialystok, Poland, Wolfson Institute for Biomedical Research, University College, London, United Kingdom, and Department of Dermatology, New Jersey Medical School, Newark, NJSearch for more papers by this authorRobert A. Schwartz MD, MPD, Robert A. Schwartz MD, MPD From the Department of Dermatology and Venereology, Medical University of Bialystok, Poland, Wolfson Institute for Biomedical Research, University College, London, United Kingdom, and Department of Dermatology, New Jersey Medical School, Newark, NJSearch for more papers by this authorBozena Chodynicka MD, PhD, Bozena Chodynicka MD, PhD From the Department of Dermatology and Venereology, Medical University of Bialystok, Poland, Wolfson Institute for Biomedical Research, University College, London, United Kingdom, and Department of Dermatology, New Jersey Medical School, Newark, NJSearch for more papers by this author First published: 07 February 2006 https://doi.org/10.1111/j.1365-4632.2004.02465.xCitations: 7 Agnieszka B. Serwin, md Department of Dermatology and Venereology Medical University of Bialystok 14, Zurawia St. 15–540 Bialystok Poland E-mail: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Chang Y, Cesarman E, Pessin MS, et al. Identification of herpervirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865–1869. 10.1126/science.7997879 CASPubMedWeb of Science®Google Scholar 2 Frederics DN, Relamn DA. Sequence-based identification of microbial pathogenesis: a reconsideration of Koch's postulates. Clin Microbiol Rev 1996; 9: 18–33. PubMedWeb of Science®Google Scholar 3 Dourmishev LA, Dourmishev AL, Schwartz RA, et al. Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Molecul Biol Rev 2003; 67: 175–212. 10.1128/MMBR.67.2.175-212.2003 CASPubMedWeb of Science®Google Scholar 4 Casper C, Wald A, Pauk J, et al. Correlates of prevalent and incident Kaposi's sarcoma-associated herpesvirus infection in men who have sex with men. J Infect Dis 2002; 185: 990–993. 10.1086/339605 PubMedWeb of Science®Google Scholar 5 Hengge UR, Ruzicka T, Stuschke M, et al. Update on Kaposi's sarcoma and other HHV8 associated diseases: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Inf Dis 2002; 2: 281–309. 10.1016/S1473-3099(02)00263-3 PubMedWeb of Science®Google Scholar 6 De Sanjose S, Marshall V, Sola J, et al. Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in Spain. Int J Cancer 2002; 98: 155–158. 10.1002/ijc.10190 CASPubMedWeb of Science®Google Scholar 7 Andreoni M, Sarmati L, Nicastri E, et al. Primary human herpesvirus 8 infection in immunocompetent children. JAMA 2002; 287: 1295–1300. 10.1001/jama.287.10.1295 PubMedWeb of Science®Google Scholar 8 Barete S, Calvez V, Mouquet C, et al. Clinical features and contribution of virological findings to the management of Kaposi sarcoma in organ-allograph recipients. Arch Dermatol 2000; 136: 1452–1258. 10.1001/archderm.136.12.1452 CASPubMedWeb of Science®Google Scholar 9 Ruocco V, Schwartz RA, Ruocco E. Lymphedema. an immunologically vulnerable site for development of neoplasms. J Am Acad Dermatol 2002; 47: 124–127. 10.1067/mjd.2002.120909 PubMedWeb of Science®Google Scholar 10 Schwartz RA, Cohen JB, Watson RA, et al. Penile Kaposi's sarcoma with penile lymphedema. Br J Dermatol 2000; 142: 153–156. 10.1046/j.1365-2133.2000.03259.x CASPubMedWeb of Science®Google Scholar 11 Schwartz RA, Lambert WC. Kaposi's sarcoma. emedicine Dermatology[Journal serial online], 2003. Available at: http://author.emedicine.com/derm/topic203.htm. Google Scholar 12 Schwartz RA. Kaposi's sarcoma: advances and perspectives. J Am Acad Dermatol 1996; 34: 804–814. 10.1016/S0190-9622(96)90018-3 CASPubMedWeb of Science®Google Scholar 13 Iscovich J, Boffetta P, Franceschi S, et al. Classic Kaposi's sarcoma. Epidemiology and risk factors. Cancer 2000; 88: 500–517. 10.1002/(SICI)1097-0142(20000201)88:3 3.0.CO;2-9 CASPubMedWeb of Science®Google Scholar 14 Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med 2000; 342: 1027–1038. 10.1056/NEJM200004063421407 CASPubMedWeb of Science®Google Scholar 15 Celleno L, Mastroianni A, Borgia MG, et al. Sacoma di Kaposi. G Ital Dermatol Venereol 1999; 134: 135–137. Google Scholar 16 De Pasquale R, Nasca MR, Micali G. Post-irradiation primary Kaposi's sarcoma of the head and neck. J Am Acad Dermatol 1999; 40: 312–314. 10.1016/S0190-9622(99)70473-1 CASPubMedWeb of Science®Google Scholar 17 Ascoli V, Zambon P, Manno D, et al. Variability in the incidence of classic Kaposi's sarcoma in the Veneto region, northern Italy. Tumori 2003; 89: 122–124. 10.1177/030089160308900203 PubMedWeb of Science®Google Scholar 18 Masini C, Lesnoni La Parola I, Capuano M, et al. Infezione da HHV8 e sarcoma di Kaposi. G Ital Dermatol Venereol 1999; 134: 315–320. Google Scholar 19 Richter F, Hill GJ, Schwartz RA. Kaposi's sarcoma: Prof. Kaposi's original concepts. J Cancer Educ 1995; 10: 113–116. CASPubMedGoogle Scholar 20 Weissmann A, Linn S, Weltfriend S, et al. Epidemiological study of classic Kaposi's sarcoma: a retrospective review of 125 cases from northern Israel. J Eur Acad Dermatol Venereol 2000; 2: 91–96. 10.1046/j.1468-3083.2000.00022.x Web of Science®Google Scholar 21 Laor Y, Schwartz RA. Epidemiologic aspects of American Kaposi's sarcoma. J Surg Oncol 1979; 12: 299–303. 10.1002/jso.2930120403 CASPubMedWeb of Science®Google Scholar 22 Klein E, Schwartz RA, Laor Y, et al. Treatment of Kaposi's sarcoma with vinblastine. Cancer 1980; 45: 427–431. 10.1002/1097-0142(19800201)45:3 3.0.CO;2-1 CASPubMedWeb of Science®Google Scholar 23 Didkowska J, Wojciechowska U, Tarkowski W, et al. Cancer in Poland in 1999. Warsaw, Poland: The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, 2002: 81–85. Google Scholar 24 Didkowska J, Wojciechowska U, Tarkowski W, et al. Cancer in Poland in 2000. Warsaw, Poland: The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, 2003: 81–85. Google Scholar 25 Simonart T, Hermans P, Van Vooren JP. Human herpesvirus 8 investigations. a role in clinical management of Kaposi's sarcoma? Dermatology (Basel) 2002; 205: 340–343. 10.1159/000066424 CASPubMedWeb of Science®Google Scholar 26 Kazakov DV, Schmid M, Adams V et al. HHV-8 DNA sequences in blood and skin lesions of multiple eruptive dermatofibromas. Dermatology (Basel) 2003; 206: 217–221. 10.1159/000068896 CASPubMedWeb of Science®Google Scholar 27 Davidovici B, Karakis I, Bourboulia D, et al. Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel. J Natl Cancer Inst 2001; 93: 194–202. 10.1093/jnci/93.3.194 CASPubMedWeb of Science®Google Scholar 28 Zhang Y-J, Davis TL, Xin-Ping W, et al. Distinct distribution of rare US genotypes of Kaposi's sarcoma-associated herpesvirus (KSHV) in south Texas: implications for KSHV epidemiology. J Inf Dis 2001; 183: 125–129. 10.1086/317650 CASPubMedWeb of Science®Google Scholar 29 Biggar RJ, Whitby D, Marshall V, et al. Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype. J Infect Dis 2000; 181: 1562–1568. 10.1086/315456 CASPubMedWeb of Science®Google Scholar 30 Schulz TF. Future trends in Kaposi's sarcoma and lymphoma. Int J STD AIDS 1998; 9: 32–34. 10.1258/0956462981921558 PubMedWeb of Science®Google Scholar Citing Literature Volume45, Issue7July 2006Pages 843-846 ReferencesRelatedInformation

Referência(s)